Delabeling penicillin allergy in a pediatric primary care clinic

Ann Allergy Asthma Immunol. 2023 May;130(5):667-669. doi: 10.1016/j.anai.2023.01.034. Epub 2023 Feb 2.

Authors

Timothy G Chow¹, Gaytri Patel², Mariya Mohammed³, Dawn Johnson⁴, David A Khan²

Affiliations

¹ Division of Allergy and Immunology, Department of Pediatrics and Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: [email protected].
² Division of Allergy and Immunology, Department of Pediatrics and Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas.
³ Neighborhood Health, Alexandria, Virginia.
⁴ Children's Health, Dallas, Texas.

PMID: 36738783
DOI: 10.1016/j.anai.2023.01.034

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / adverse effects
Child
Drug Hypersensitivity* / diagnosis
Humans
Hypersensitivity*
Penicillins / adverse effects
Primary Health Care
Skin Tests

Substances

Penicillins
Anti-Bacterial Agents

Associated data

ClinicalTrials.gov/NCT05010304